In a major victory for the generic pharmaceuticals industry, the Supreme Court yesterday ruled that patients can't sue firms over copycat drugs that are allegedly unsafe. The court quashed a New Hampshire jury's decision to award $21M to a woman who developed a debilitating skin disease after she took a generic version of the pain treatment sulindac made by a unit of India's Sun Pharmaceutical.
In a major victory for the generic pharmaceuticals industry, the Supreme Court yesterday ruled...
From other sites
Video at CNBC.com (Fri, 5:58PM)
Video at CNBC.com (Fri, 5:30PM)
Video at CNBC.com (Fri, 6:00AM)
Video at CNBC.com (Thu, 7:09AM)
Video at CNBC.com (May 10, 2016)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs